Sri Lankan Rupee Decline Forces Medicine Price Hike

The value of the Sri Lankan rupee has fallen significantly, prompting an adjustment in the maximum prices for 60 different types of medicine. The National Medicines Regulatory Authority confirmed that the price revision is a direct consequence of the increasing value of the US dollar.

This decision by the regulatory authority will directly affect the affordability of essential pharmaceuticals for the Sri Lankan population. As the rupee weakens against the dollar, the cost of imported medicines, which constitute a significant portion of the market, inevitably rises.

The price hike for these 60 medicine types underscores the broader economic challenges Sri Lanka is facing, where currency depreciation has a tangible impact on the cost of living and access to essential goods, including healthcare.

Further details on the specific medicines affected and the extent of the price increases are expected as the National Medicines Regulatory Authority implements these changes.